Break out Stocks by Nilesh Kotak

GLAXO Pharma Momentum Buy for 28 August 2026 – Short-Term Trading Strategy

⭐ Momentum Pick ⭐⭐⭐⭐ — GLAXO Pharma

GLAXO Pharma is selected as a Momentum Buy for 28 August 2026 with a strict entry above Rs. 3,050. This is a 5–7 trading day setup, not a 4–6 week positional recommendation. Investors should buy only at the specified trigger and avoid chasing the stock substantially above the recommended entry level.

Trade Setup

Important: Buy only around the recommended trigger. If the stock opens sharply higher and runs substantially beyond the entry level, do not chase.

Profit-Booking Strategy

Once Target 1 at Rs. 3,085 is achieved:

• Sell 50% of the position at Rs. 3,085.
• Continue holding the remaining 50% for Rs. 3,115.
• Immediately raise the stop loss on the balance quantity to the cost price around Rs. 3,050.
• This converts the remaining portion into a substantially protected trade after the first target is achieved.

Why GLAXO Pharma Is a Momentum Buy

GLAXO Pharma is showing a powerful short-term technical structure. The stock is bullish over the 5-day and 21-day timeframes, although the 63-day classification continues to remain bearish. The recent price action, however, indicates that the medium-term recovery has gathered considerable strength.

The stock has gained 16.86% in one month and 34.47% in three months, demonstrating strong momentum. It is trading substantially above all the important moving averages, including the 20-DMA at Rs. 2,770, 34-DMA at Rs. 2,668, 50-DMA at Rs. 2,579 and 200-DMA around Rs. 2,467.

This moving-average alignment is clearly bullish and indicates that buyers are presently dominating the price structure.

The MACD is particularly supportive, standing at 134.45 against a signal line of 109.02, with a positive histogram of 25.43. This confirms that short-term momentum remains positive.

The strength of the trend is further supported by ADX at 41.53, which represents a very strong directional trend. More importantly, +DMI at 40.57 is far above -DMI at 12.01, indicating a decisive advantage for buyers.

The One Important Warning: RSI Is Overheated

GLAXO does not completely satisfy our normal high-conviction selection criterion of RSI between 56 and 68. Its RSI is currently 76.13, which places the stock in an overbought zone.

Stochastic readings are also elevated at 81.66 / 72.91, while Williams %R at -9.02 and Stochastic RSI %K at 100 confirm that momentum has become stretched.

This is precisely why we classify GLAXO as a ⭐⭐⭐⭐ Momentum Pick, rather than a ⭐⭐⭐⭐⭐ 4–6 week High Conviction Pick.

The setup should therefore be approached as a disciplined 5–7 trading day momentum trade with predetermined targets, rather than as an open-ended positional investment.

Why Rs. 3,050 Is the Key Entry Level

The Camarilla support structure places an important level around Rs. 3,050.93, making the Rs. 3,050 region technically significant. Meanwhile, the main pivot is around Rs. 3,068.67.

On the upside, resistance clusters appear around Rs. 3,078–3,096, followed by Rs. 3,106–3,124. This supports our staged profit-booking strategy at Rs. 3,085 and Rs. 3,115.

The stock is also approaching its 52-week high of Rs. 3,118, meaning the second target deliberately lies close to a major supply zone.

Paresh Gordhandas View

GLAXO Pharma is a strong momentum candidate for 28 August, backed by positive MACD, ADX above 40, exceptionally strong +DMI dominance and price trading comfortably above all major moving averages. However, RSI at 76.13 indicates that the stock is already somewhat overheated. Hence, discipline is crucial. Buy only above Rs. 3,050 at the recommended rate, with a strict stop loss of Rs. 2,975. Book 50% at Rs. 3,085 and hold the balance for Rs. 3,115. Once the first target is achieved, shift the stop loss on the remaining quantity to the original cost price.

Verdict: ⭐⭐⭐⭐ Momentum Buy | 5–7 trading days | Buy above Rs. 3,050 only | T1 Rs. 3,085 | T2 Rs. 3,115 | SL Rs. 2,975.